Mandelay

Manufacturer
Majestic Drug Co., INC.
Effective date
2017-11-09
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-05-31 22:53:03

Label at a glance#

ProductMandelay Male Genital Desensitizer
Active ingredientBenzocaine
Label structure8 sections

Indications and uses

Helps in temporarily prolonging the time until ejaculation

Dosage and administration

Apply a small amount to head and shaft of penis 2-3 minutes before intercourse, or use as directed by a physician. Wash product off after intercourse.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Benzocaine 7.5%

Purpose

OTC - PURPOSE SECTION

Male genital desensitizer

Uses

INDICATIONS & USAGE SECTION

  • Helps in temporarily prolonging the time until ejaculation

Warnings

WARNINGS SECTION

For external use only

When using this product

OTC - WHEN USING SECTION

  • Avoid contact with eyes

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • this product, used as directed,does not provide relief. Premature ejaculation may be due to condition requiring medical supervision.
  • you or your partner develop a rash or irritation, such as burning or itching.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Apply a small amount to head and shaft of penis 2-3 minutes before intercourse, or use as directed by a physician.
  • Wash product off after intercourse.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Carbowax, Carbomer 974P.

PRINCIPAL DISPLAY PANEL - 28.35 g Tube Box

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

MANDELAY®

Climax Control Gel

NET WT 1.0 OZ. (28.35g)

PRINCIPAL DISPLAY PANEL - 28.35 g Tube Box
PRINCIPAL DISPLAY PANEL - 28.35 g Tube Box

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
BENZOCAINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
10705-077-012022-01-28C16284748780-1d6a99b39-82ae-a426-e053-dadaa90af4c2MANDELAY ®

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
10705-077-01Mandelay Male Genital Desensitizer1 in 1 BOXGEL13
10705-077-28Mandelay Male Genital Desensitizer28.35 g in 1 TUBEGEL28.353

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
10705-077MANDELAY MALE GENITAL DESENSITIZER (BENZOCAINE) GEL [MAJESTIC DRUG CO., INC.]3Legacy NDC, 2 package rows20171122_6fa0273f-d8c7-40df-b179-847b3ffaed2d.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
BenzocaineACTIVE INGREDIENTU3RSY48JW51
BenzocaineACTIVE MOIETYU3RSY48JW51
Carbomer Homopolymer Type B (Allyl Pentaerythritol Crosslinked)INACTIVE INGREDIENTK61870Z3081

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
10705-07710705-077-28, 10705-077-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d2a5e150-5fe4-483a-a5ca-39b58e42f95f6fa0273f-d8c7-40df-b179-847b3ffaed2d2017-11-09WarningsExact identifier
spl id: d2a5e150-5fe4-483a-a5ca-39b58e42f95f
spl set id: 6fa0273f-d8c7-40df-b179-847b3ffaed2d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.